Corporate Council

Honorable John D. Rockefeller IV (D-WV),
United States Senate

Trustees

Deerfield Foundation
Alex Karnal, Chairman
Jeff Kaplan, Partner

GlaxoSmithKline
David Pulman, Ph.D., President, Global Manufacturing & Supply
Bill Shore, Director, U.S. Community Partnerships

The Great Atlantic & Pacific Tea Company, Inc.
Christian W.E. Haub, Executive Chairman

MediaCom
Doug Checkeris, CEO, North America
Matthew Schwach, Managing Partner, Account Director

sanofi-aventis U.S.,
Greg Irace, President & CEO

UnitedHealth Group
Reed V. Tuckson, MD, FACP, Executive Vice President & Chief of Medical Affairs, UnitedHealth Group
Daniel S. Johnson, President & Executive Director, UnitedHealth Foundation

Wyeth

Steering Commitee

sanofi pasteur
Damian Braga, President
Julianne Burk, Strategic Advocacy Deputy Director

Schering-Plough Corporation

Siemens Medical Solutions USA, Inc.
Don Rucker, MD, Vice President/Chief Medical Officer
Lance Longwell, Director, Public Relations

Partners

ACE Limited
Evan Greenberg, President & CEO

Chandler Chicco Companies
Robert Chandler, Founder and Principal
Gloria M. Janata, JD, Global Executive Council and Team Leader

Merck & Co.
Mark Feinberg, M.D., Vice President, Policy & Public Health

Morgan Stanley
Tom Nides, Chief Administrative Officer
Joan Steinberg, Executive Director, President of the Morgan Stanley Foundation

Members

Bristol-Myers Squibb Company
Jill DeSimone, Senior Vice President, Virology Marketing
Ron Miller, Senior Director, Public Policy

Centerbridge Foundation
Carrie F. Braddock, Foundation Director
Steve M. Silver, Senior Managing Director, Centerbridge Partners

Children’s Health Fund (CHF) works with major corporations, foundations and government agencies to create cooperative alliances that bring together participants’ strengths and experience. Together these organizations create a unified voice for children under the umbrella of Children’s Health Fund’s Corporate Council for America’s Children.

With the leadership of U.S. Senator John D. Rockefeller IV (D-WV), David Pulman, PhD, President, Global Manufacturing & Supply of GlaxoSmithKline and Irwin Redlener, MD, the Corporate Council meets to discuss health reform, legislation and other issues that impact children. Council members provide ongoing financial support to sustain and expand CHF's affiliated programs and special initiatives.

By joining the Corporate Council, participating companies may designate up to two Delegates, typically the CEO or President and another senior executive, who are invited to participate in the Annual Meeting in Washington, D.C., as well as other high-level policy events sponsored by CHF. Council members are listed on CHF’s letterhead, Gala invitations, other printed materials, and on its website. Furthermore, each contribution level entitles the corporate members to a variety of partnership recognition opportunities, including sponsorship of special events, designated child health programs and/or cause-marketing campaigns.

Contribution levels for Corporate Council membership

Corporate Council Trustee:
$1 million within a maximum 4-year period

Steering Committee Member:
$300,000 within a maximum 3-year period

Partner:
$100,000 within a maximum 2-year period

Member:
$50,000 first year, in subsequent years renewal at Partner level required